This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genkyotex Suisse Sa. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: John M Ellard: Innovator in Pharmaceutical Chemistry
Introduction
John M Ellard is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Ellard holds a patent for "Amido thiadiazole derivatives as NADPH oxidase inhibitors." This invention relates to amino thiazole derivatives of Formula (I), pharmaceutical compositions thereof, and their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). He has 1 patent to his name.
Career Highlights
Throughout his career, Ellard has focused on innovative solutions in drug development. His work has contributed to advancements in understanding and treating conditions associated with NADPH oxidase, showcasing his expertise in medicinal chemistry.
Collaborations
Ellard has collaborated with notable colleagues, including Peter J Machin and Andrew Sharpe. These partnerships have enhanced his research and development efforts, leading to impactful innovations in the pharmaceutical industry.
Conclusion
John M Ellard is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the field. His innovative approach to drug development exemplifies the importance of targeted therapies in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile